Among the most effective immunotherapeutic strategies are immune ICIs, which target checkpoints such as PD-L1 and PD-1, thereby enhancing the cytotoxicity and proliferation of tumor-infiltrating immune cells [26]. Here, PDCD1 is linked to neoplasm.